MEDIFAST INC (MED)
Official siteCONSUMER CYCLICAL • PERSONAL SERVICES • NYSE
Market Cap: $140.23M
Last updated: Nov 17, 2026 at 4:15 PM ET
MEDIFAST INC (MED) Stock Chart
MEDIFAST INC (MED) has a latest price of $12.22 on Nov 17, 2026, 10.3% below its 52-week high of $13.63. Its price rose 7.4% over the past 12 months. The month-end price fell 70.4% over the 10 years through Oct 2026, a compound annual decline of 11.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $332.25 in May 2021 and its lowest $9.83 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MED with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MED.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 5.6%, and over 6 months it fell 2.9%. The month-end price fell 82.4% over the 3 years through Oct 2026, a compound annual decline of 44.0%.
| Period | Change |
|---|---|
| 1 month | +1.6% |
| 3 months | +5.6% |
| 6 months | -2.9% |
| 12 months | +7.4% |
| 12 months, with dividends | +7.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.4% | -44.0% |
| 5 years | -93.8% | -42.7% |
| 10 years | -70.4% | -11.5% |
Price by Year
Its best calendar year was 2020, when the price rose 79.2%, and its weakest was 2024, when it fell 73.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $12.15 | +13.8% |
| 2025 | $10.68 | -39.4% |
| 2024 | $17.62 | -73.8% |
| 2023 | $67.22 | -41.7% |
| 2022 | $115.35 | -44.9% |
| 2021 | $209.43 | +6.7% |
| 2020 | $196.34 | +79.2% |
| 2019 | $109.58 | -12.4% |
| 2018 | $125.02 | +79.1% |
| 2017 | $69.81 | +67.7% |
Trading Range
The price is 0.8% above its 50-day average of $12.13 and 7.3% above its 200-day average of $11.39.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $12.22 | |
| 52-week high | $13.63 | -10.3% |
| 52-week low | $9.22 | +32.6% |
| 50-day average | $12.13 | +0.8% |
| 200-day average | $11.39 | +7.3% |
Price Risk
Over 3 years, its largest fall from a peak was 87.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.14 |
| Largest fall, 1 year | -28.1% |
| Largest fall, 3 years | -87.5% |
Valuation
MEDIFAST INC traded at 8.7x earnings at the end of 2024, against a 5-year median of 7.9x and a 10-year median of 17.1x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MED
What is MED's 1-year price change?
MEDIFAST INC's price rose 7.4% over the past 12 months. With dividends included, the 12-month total return was 7.4%.
What is MED's 5-year price change?
MEDIFAST INC's month-end price fell 93.8% over the 5 years through Oct 2026, a compound annual decline of 42.7%. These figures leave out dividends.
What is MED's 52-week high and low?
MEDIFAST INC's 52-week high is $13.63 and its 52-week low is $9.22. Its latest price of $12.22 on Nov 17, 2026 is 10.3% below the high.
What is MED's beta?
MEDIFAST INC's 1-year beta against the S&P 500 is 1.14, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 28.1%.
Is the MED chart free?
Yes. Advanced Charting for MED is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MED pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors